Standout Papers

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in <i>UB... 2021 2026 2022 2024136
  1. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1 (2021)
    Ifeyinwa E. Obiorah, Bhavisha A. Patel et al. Blood Advances

Immediate Impact

7 standout
Sub-graph 1 of 4

Citing Papers

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment
2025 Standout
Flavonoids as dual-target inhibitors against α-glucosidase and α-amylase: a systematic review of in vitro studies
2024 Standout
2 intermediate papers

Works of Weixin Wang being referenced

miR-181c regulates MCL1 and cell survival in GATA2 deficient cells
2021
The Chemistry and Health Benefits of Dietary Phenolamides
2020

Author Peers

Author Last Decade Papers Cites
Weixin Wang 74 28 26 124 100 14 274
Ganpeng Yu 124 12 20 98 25 14 306
Daniel Chiu 123 48 11 21 64 11 311
Jason L. Liggett 97 34 11 82 14 11 314
Magdalena Koszarska 111 96 5 31 93 12 226
Sophia Hatziieremia 115 93 11 43 79 10 325
Yating Chong 124 36 11 36 30 15 227
Elia Mattarucchi 150 60 27 20 42 12 296
Evelyn Damgaard 71 23 11 23 22 11 299
In-Uk Koh 167 29 28 18 16 14 335
Wolfgang Schwaiger 158 5 11 62 20 8 320

All Works

Loading papers...

Rankless by CCL
2026